Goodwin Advises LifeMine Therapeutics on Raising $263M for a Safer Immunosuppressant
August 06, 2026
August 06, 2026
BOSTON, Massachusetts, Aug. 6 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises LifeMine Therapeutics on Raising $263M for a Safer Immunosuppressant
*
The Life Sciences team advised LifeMine Therapeutics on raising $263 million in funding to accelerate the clinical development of the company's lead program, LIFE-001, and advance its pipeline of novel transplantation and immunology the . . .
* * *
Goodwin Advises LifeMine Therapeutics on Raising $263M for a Safer Immunosuppressant
*
The Life Sciences team advised LifeMine Therapeutics on raising $263 million in funding to accelerate the clinical development of the company's lead program, LIFE-001, and advance its pipeline of novel transplantation and immunology the . . .